Microfluidic devices and methods for bioassays
10821441 ยท 2020-11-03
Assignee
Inventors
Cpc classification
B01L2200/12
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502707
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502784
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/041
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502715
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0816
PERFORMING OPERATIONS; TRANSPORTING
B01L2400/084
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/087
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502761
PERFORMING OPERATIONS; TRANSPORTING
International classification
Abstract
A microfluidic device includes a substrate and a cover. The substrate has an inlet port, a first microchannel, one or more parking loops, a second microchannel and an outlet port for each microchannel network. The first microchannel is connected to the inlet port, the second microchannel is connected to the outlet port, the parking loops are connected between the first and second microchannels. Each parking loop includes a parking loop inlet, a parking loop output, a fluidic trap connected between the parking loop inlet and the parking loop outlet, and a bypass microchannel connected to the parking loop inlet and the parking loop outlet. The cover is attached to a top of the substrate and has an inlet opening and an outlet opening through the cover for each microchannel network. The inlet and outlet openings of the cover are disposed above the inlet and outlet ports in the substrate.
Claims
1. A method for storing a sample within a microfluidic device having one or more microchannel networks comprising: providing the microfluidic device comprising: a substrate having an inlet port, a first microchannel, one or more parking loops, a second microchannel and an outlet port for each microchannel network, wherein the first microchannel is connected to the inlet port, the second microchannel is connected to the outlet port, the one or more parking loops are connected between the first microchannel and the second microchannel, and each parking loop comprises a parking loop inlet, a parking loop output, a fluidic trap connected between the parking loop inlet and the parking loop outlet, and a bypass microchannel connected to the parking loop inlet and the parking loop outlet, and a cover attached to a top of the substrate, the cover having an inlet opening and an outlet opening through the cover for each microchannel network, wherein the inlet opening of the cover is disposed above the inlet port in the substrate and the outlet opening is disposed above the outlet port in the substrate; storing the sample within the microfluidic device by: releasing a first oil into the inlet port of the substrate via the inlet opening using a pipette and allowing the first oil to move from the inlet port to the outlet port by a capillary suction; releasing the sample into the inlet port of the substrate via the inlet opening using the pipette; filling each fluidic trap with the sample by creating a suction in the outlet port of the substrate via the outlet opening using the pipette; releasing a second oil into the inlet port of the substrate via the inlet opening using the pipette; removing the sample from the first microchannel, the parking loop inlet, the bypass microchannel, the parking loop outlet and the second microchannel of each microchannel network using the second oil, and storing the sample in each fluidic trap, by creating a suction in the outlet port of the substrate via the outlet opening using the pipette; and filling the inlet port, the first microchannel, the second microchannel, the outlet port and the bypass channel of each parking loop with a third oil such that the sample remains in each fluidic trap and a level of the third oil is above the inlet port and the outlet port.
2. The method as recited in claim 1, wherein the fluidic trap comprises: a trap repository connected to the parking loop inlet; and a trap microchannel connecting the trap repository to the parking loop outlet, wherein a cross-sectional area of the trap microchannel is smaller than a cross-sectional area of the bypass microchannel.
3. The method as recited in claim 2, wherein the trap repository has a volume of about 10, 20, 30, 40, 50, 60, 70, 80 or 90 nL.
4. The method as recited in claim 2, wherein: the first microchannel, the second microchannel and the bypass microchannel have a width of about 200 m and a height of about 200 m; the trap repository has a diameter of about 450 m; the trap microchannel has a width of about 40 m; and the first microchannel, the second microchannel, the bypass microchannel, the trap repository and the trap microchannel have a height of about 200 m.
5. The method as recited in claim 4, wherein the trap microchannel has a length of about 100 m.
6. The method as recited in claim 1, further comprising the step of automatically controlling the pipette with a processor communicably coupled to the pipette.
7. The method as recited claim 6, wherein: the one or more microchannel networks comprise two or more microchannel networks forming an array microchannel networks; the pipette comprises one pipette for each microchannel network; and the method is performed simultaneously for the microchannel networks.
8. The method as recited claim 1, wherein: the one or more microchannel networks comprise at least a first microchannel network and a second microchannel network; the first microchannel network contains the sample having a first concentration; and the second microchannel network contains the sample having a second concentration.
9. The method as recited claim 1, wherein: the one or more microchannel networks comprise at least a first microchannel network and a second microchannel network; the sample comprises a first sample and a second sample; the first microchannel network contains the first sample; and the second microchannel network contains the second sample.
10. The method as recited in claim 1, wherein the sample comprises one or more drops, cells or compositions.
11. The method as recited in claim 1, wherein a hydrodynamic resistance ratio between the fluidic trap and the bypass microchannel is from 1.0 to 2.0, and a hydrodynamic resistance of the bypass microchannel is smaller than a hydrodynamic resistance of the fluidic trap.
12. The method as recited in claim 1, wherein a hydrodynamic resistance ratio between the fluidic trap and the bypass microchannel is from 1.4 to 1.6, and a hydrodynamic resistance of the bypass microchannel is smaller than a hydrodynamic resistance of the fluidic trap.
13. The method as recited in claim 1, wherein the one or more parking loops comprise at least four parking loops.
14. The method as recited in claim 1, wherein the one or more microchannel networks comprise two or more microchannel networks forming an array microchannel networks.
15. The method as recited in claim 1, wherein a diameter of the inlet opening and the outlet opening of the cover have a diameter of about 3 mm.
16. The method as recited in claim 1, wherein: the inlet port in the substrate comprises a reservoir; and the inlet opening of the cover is aligned with the reservoir in the substrate.
17. The method as recited in claim 1, wherein the cover reduces an evaporation of the sample stored in the fluidic trap(s) and increases a viability of the sample stored in the fluidic trap(s).
18. The method as recited in claim 17, wherein the evaporation of the sample stored in the fluidic trap(s) is less than 10% during 48 hours.
19. The method as recited in claim 1, further comprising soaking the microfluidic device in a distilled water prior to storing the sample within the microfluidic device.
20. The method as recited in claim 1, further comprising placing the microfluidic device in a water filled omni-plate with a lid after storing the sample within the microfluidic device.
Description
DESCRIPTION OF THE DRAWINGS
(1) The above and further advantages of the invention may be better understood by referring to the following description in conjunction with the accompanying drawings, in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
DESCRIPTION OF THE INVENTION
(15) While the making and using of various embodiments of the present invention are discussed in detail below, it should be appreciated that the present invention provides many applicable inventive concepts that can be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the invention and do not delimit the scope of the invention.
(16) Various embodiments of the present invention provide a microfluidic device for storing arrays of nanoliter droplets. Although the microfluidic device 100 described herein is well suited for use with automated multichannel pipettes 102 as shown in
(17) For example,
(18) Each embedded microchannel network 104 contains an inlet port or reservoir 106, a first microchannel 108, one or more parking loops 110 (e.g., four parking loops 110a, 110b, 110c and 110d), a second microchannel 112 and an outlet port 114. The first microchannel 108 is connected to the inlet port 106 and the second microchannel 112 is connected to the outlet port 114. The one or more parking loops 110 are connected between the first microchannel 108 and the second microchannel 112. As shown in
(19) The hydrodynamic resistance ratio between the fluidic trap 120 and bypass microchannel 122 is typically from 1.0 to 2.0, and may be between 1.4 to 1.6 in order to trap and store replicates of nanoliter-scale fluid volumes. In the example, each parking loop 110 has the following dimensions: the first microchannel 108, the second microchannel 112 and the bypass microchannel 122 have a width of approximately 200 m and a height of approximately 200 m; the trap repository 124 has a diameter of approximately 450 m; the trap microchannel 126 has a width of approximately 40 m; the first microchannel 108, the second microchannel 112, the bypass microchannel 122, the trap repository 124 and the trap microchannel 126 have a height of approximately 200 m; and the trap microchannel 126 has a length of approximately 100 m. Each fluidic trap 124 has a volume of only 30 nL in contrast to the 1-10 L that is currently used in standard multiwell plate. Other dimensions and volumes can be used. For example, volume of the trap repository 124 can be approximately 10, 20, 30, 40, 50, 60, 70, 80, 90 nL or any increment thereof.
(20) As will be explained in more detail below and as shown in
(21) More information about other embodiments are described in U.S. patent application Ser. No. 14/114,304 filed on May 7, 2012 and entitled Methods and Devices to Control Fluid Volumes, Reagent and Particle Concentration in Arrays of Microfluidic Drops, which is hereby incorporated by reference in its entirety.
(22) Now referring to
(23) Referring now to
(24) Similarly,
(25) Note that the pipette can be automatically controlled with a processor communicably coupled to the pipette. Moreover, multiple microchannel networks can be filled simultaneously. For example, a first microchannel network can contain the sample having a first concentration, a second microchannel network can contains the sample having a second concentration. Likewise, a first microchannel network can contain a first sample, and a second microchannel network can contain a second sample. The sample may include one or more drops, cells or compositions.
(26) Various embodiments of the present invention were tested as described below. Solutions of red, green, blue, purple and orange dyes (McCormick) were diluted 10 by distilled water and used as reagent plugs. 0.001% (w/w) biocompatible fluorosurfactant, KrytoxFSH-PEG600-KrytoxFSH (RAN Biotechnologies, Inc., MA) in FC-40 (Sigma-Aldrich) was used as carrier fluid. Human leukemia cancer cell line CCRF-CEM was maintained and grown in RPMI-1640 medium containing 10% fetal bovine serum and 0.1% Insulin-Transferrin-Selenium at 37 C. in 5% CO2. Cell density of 3.5106 cells/mL was used in the experiments. LIVE/DEAD Cell Imaging Kit (Life technologies) was used to stain the cells for the cell viability test. Preliminary cytotoxicity assays performed with the anticancer drug doxorubicin.
(27) The versatility of the pipette-integrated microfluidic well plate device in accordance with the present invention is illustrated in
(28) To perform cell culture or drug dose response assay in nanoliter-scale, the preservation of drop content over a period of time is very crucial. To avoid the liquid evaporation from the trapped drop over time, oil-filled pipette tips were initially used in both of the ports of the device. However, an 30% sample evaporation was observed over 48 hours. Therefore, several strategies for reducing the evaporation during the incubation were explored. An effective method involves the plasma bonding of a second layer of PDMS sheet of 1 mm thickness with 3 mm holes aligned with the inlet and outlet ports of each SDA in the bottom layer. Then, the device is soaked in distilled water for 3 days. After 3 days, the device is used and after finishing the droplet trapping process, all of the 3 mm holes in the second layer are filled with oil to create oil reservoirs above the inlet and outlet of the SDAs. Then, the device was put in water filled omni-plate with a lid and stored in the incubator. Potential loss of reagent fluid due to evaporation in this process was less than 10% during 48 hours. The data is shown in
(29) The quantification of cell distribution in drops was also tested. Different stock cell densities were used to get an idea of cell distribution in each microchannel using pipette-integrated droplet trapping. Two stock solutions of cells (density of 3106 and 8106 cells/mL) with a target of 50-250 cells/drop were prepared to get about 200-1000 cells per SDA, which gave a better statistic for future assay analysis. The actual cell distribution in 6-SDAs is shown in
(30) Previously, cell viability in 16 nL drop of a density of 30 cells/drop was tested. The previous data showed greater than 90% cells are viable up to 4.5 hours without any media replacement. A similar cell viability test was performed using the microfluidic device in accordance with the present invention with a 30 nL drop volume. A cell density of 3106 cells/mL was used to get about 100 cells per SDA to assess the viability of cells during the culture. Cells diluted with only media and without any drugs are used as controls. The cells are staining with live and dead fluorescent dyes prior to the trapping process. Standard epifluorescence microscopy automated stage was used with to image viable cells. A greater than 90% cell viability over 20 hours in 8-SDAs without any media replacement was observed. The results are shown in
(31) In addition, preliminary cytotoxicity assays were performed using the anticancer drug doxorubicin in the microfluidic device in accordance with the present invention. A concentration 0.75106 cells/mL strained with live/dead cell imaging kit was used. In one SDA controlled cell trapping (without drug) was performed and in another SDA the cells were exposed to 1 M doxorubicin before trapping and the cell viability over time was observed in both of the SDAs. Preliminary cytotoxicity assays with the anticancer drug doxorubicin showed greater than 99% cell death over 6 hour incubation period (
(32) Further, to determine dose-dependent cytotoxicity of the doxorubicin, leukemia cells were exposed to different concentrations of drug and each concentration treated cells were trapped in a separate SDA of the microfluidic device, and then the device was incubated for 1 hour, after which the cell viability was determined by standard image based epifluorescence microscopy. The IC50 value of the doxorubicin in the leukemia cell lines was found 430 nM (
(33) The foregoing description of the apparatus and methods of the invention in preferred and alternative embodiments and variations, and the foregoing examples of processes for which the invention may be beneficially used, are intended to be illustrative and not for purpose of limitation. The invention is susceptible to still further variations and alternative embodiments within the full scope of the invention, recited in the following claims.